FDA Peptide Reclassification 2026: What Researchers Want FDA Removes 14 Peptides from Category 2 to Category 1 Mansi Hukmani posted on the topic LinkedIn The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Tesamorelin vs CJC 1295 Ipamorelin: FDA Approved vs Dual Pathway PeRx Blog An appraisal of FDA approvals for adult solid tumours in 20172021: has the eagle landed? Nature Reviews Clinical Oncology